Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.72 USD | +2.64% | +17.53% | -35.51% |
26/04 | UBS Cuts CureVac Price Target to $14 From $18, Maintains Buy Rating | MT |
25/04 | Leerink Partners Downgrades CureVac to Market Perform From Outperform, Sets Price Target at $4 | MT |
Official Publications
No official publication found
- Stock Market
- Equities
- CVAC Stock
- News CureVac N.V.
- Official Publications